Literature DB >> 16843296

Lactic acidosis in thiamine deficiency.

C Madl1, A Kranz, B Liebisch, O Traindl, K Lenz, W Druml.   

Abstract

Two chronically ill patients with limited nutritional intake during several weeks developed prolonged lactic acidosis. As no other causes of hyperlactaemia could be identified, thiamine deficiency was suspected. Supplementation of 600 mg thiamine resulted in a rapid normalisation of serum lactate levels (in patient 1 from 10.9-2.4 mmol/l; in patient 2 from 11.8-2.0 mmol/l) and acid base status (patient 1: pH from 7.11-7.30, bicarbonate from 8.6-21.2 mmol/l; patient 2: pH from 7.24-7.46, bicarbonate from 16-28 mmol/l; before and after treatment, respectively). Thiamine deficiency was confirmed by the degree of stimulation of erythrocyte transketolase activation by adding thiamine pyrophosphate, evaluated before and after thiamine replacement therapy. Stimulation decreased in patient 1 from 170% to 17% and in patient 2 from 20% to 0%, respectively. In addition to the metabolic derangement right ventricular heart failure was confirmed by echocardiography in both patients and again this was rapidly reversible by thiamine supplementation. We conclude that in malnourished patients unexplained prolonged lactic acidosis may result from thiamine deficiency, which is rapidly reversible by thiamine replacement therapy.

Entities:  

Year:  1993        PMID: 16843296     DOI: 10.1016/0261-5614(93)90060-h

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  2 in total

Review 1.  Thiamine Deficiency in Tropical Pediatrics: New Insights into a Neglected but Vital Metabolic Challenge.

Authors:  Laurent Hiffler; Benjamin Rakotoambinina; Nadia Lafferty; Daniel Martinez Garcia
Journal:  Front Nutr       Date:  2016-06-14

2.  Thiamine status and lactate concentration in sepsis: A prospective observational study.

Authors:  Nicholas Heming; Amor Salah; Paris Meng; Sivanthiny Sivanandamoorthy; Rania Bounab; Sylvie Chevret; Djillali Annane
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.